Form 4: Bioxytran Director Dale H. Conaway Acquires 266,955 Shares of Common Stock

Director Dale H. Conaway increased his holdings in Bioxytran, Inc. by acquiring 266,955 shares of common stock at $0.114 per share on March 27, 2024.

Summary

• On March 27, 2024, Dale H. Conaway, a director of Bioxytran, Inc., acquired 266,955 shares of the company's common stock.
• The shares were purchased at a price of $0.114 per share.
• Following the transaction, Conaway's total holdings in Bioxytran common stock increased to 855,476 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director buying shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's performance.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates a director's increased investment in the company.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders, as insider buying is often seen as a sign of confidence in the company's prospects.

Key Dates

Keywords

Bioxytran, Director, Stock Acquisition, Form 4, BIXT, Common Stock, Beneficial Ownership, Securities